Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
28.9M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
5.73M
-
Shares change
-
+918K
-
Total reported value, excl. options
-
$71.5M
-
Value change
-
+$11.5M
-
Number of buys
-
39
-
Number of sells
-
-25
-
Price
-
$12.47
Significant Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q3 2023
78 filings reported holding HQL - abrdn Life Sciences Investors - Common Shares, $0.01 par value as of Q3 2023.
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.73M shares
of 28.9M outstanding shares and own 19.86% of the company stock.
Largest 10 shareholders include 1607 Capital Partners, LLC (479K shares), Allspring Global Investments Holdings, LLC (348K shares), RPO LLC (327K shares), WOLVERINE ASSET MANAGEMENT LLC (322K shares), NEEDHAM INVESTMENT MANAGEMENT LLC (314K shares), Cornerstone Advisors, LLC (285K shares), AQR Arbitrage LLC (272K shares), Saba Capital Management, L.P. (272K shares), Logan Stone Capital, LLC (249K shares), and FLAGSHIP HARBOR ADVISORS, LLC (231K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.